Fundraising Fox

Mittie Doyle

Investor

Chief Medical Officer at Avalo Therapeutics

Greater Boston

About

Research physician with over 20 years of pharma and biotech experience and numerous clinical development leadership roles. Most recently Chief Medical Officer at Aro Biotherapeutics; previously held senior immunology and therapeutic area head positions at CSL Behring, Shire, Flexion, and Alexion, advancing assets across immune-mediated and orphan disease indications.

Experience

  1. Cullinan TherapeuticsIndependent Board Membercurrent2025 — present
  2. Avalo TherapeuticsChief Medical Officercurrent2024 — presentWayne, PA
  3. Santa Ana Bio, Inc.Independent Board Membercurrent2023 — present
  4. Aro BiotherapeuticsChief Medical Officer2021 — 2024Philadelphia, Pennsylvania, United States
  5. DICE Therapeutics (acquired by Eli Lilly & Co.)Independent Board Member2022 — 2023
  6. CSL BehringVice President, Group Head Immunology and Inflammation2017 — 2021King of Prussia, PA
  7. ShireVice President, Global Development Lead2016 — 2017
  8. Flexion TherapeuticsVice President, Clincal Research2015 — 2016Burlington, MA
  9. Alexion PharmaceuticalsSenior Medical Director2012 — 2015Cambridge, MA
  10. CentocorDirector Janssen R&D, Clinical Immunology2009 — 2012Spring House, PA
  11. Centocor R&DAssociate Director2006 — 2009Chesterbrook, PA
  12. Tulane University School of MedicineAssistant Professor of Clinical Medicine2002 — 2006New Orleans, LA
  13. Harvard Medical SchoolInstructor in Medicine1996 — 1999

Skills & more

Clinical Trials26Medical Writing5Lifesciences3Biotechnology20R&D13Neurology3Immunology30Medicine16Drug Development14Clinical Research14Healthcare2Clinical Development18
+7 moreBiomarkersRheumatologyNeuroscienceMedical AffairsOncologyLife SciencesResearch and Development (R&D)

From Mittie's professional profile.

Colleagues at Avalo Therapeutics

Aaron Kantoff
Managing Partner at Scion Life Sciences
Aaron Kantoff
Board Member at Avalo Therapeutics
Amy Conrad
Senior Events Manager at Volta Labs
Amy Conrad
Director of Events & Community Engagement at Volta
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics

Frequently asked questions

Who is Mittie Doyle?
Research physician with over 20 years of pharma and biotech experience and numerous clinical development leadership roles. Most recently Chief Medical Officer at Aro Biotherapeutics; previously held senior immunology and therapeutic area head positions at CSL Behring, Shire, Flexion, and Alexion, advancing assets across immune-mediated and orphan disease indications.
Where does Mittie Doyle work?
Mittie Doyle is Chief Medical Officer at Avalo Therapeutics.
Where did Mittie Doyle go to school?
Mittie Doyle studied at Harvard Medical School (Fellowship - Brigham and Women's Hospital, Rheumatology and Immunology); Harvard Medical School - Massachusetts General Hospital (Internal Medicine Residency Program); Yale School of Medicine (Doctor of Medicine (MD)).

Same school

Also attended Harvard Medical School176

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 170 more

Also attended Harvard Medical School - Massachusetts General Hospital7

Barry SteinVice President, Chief Clinical Innovation Officer and Chief Medical Informatics Officer at Flare Capital PartnersHagai Marmor-KolletAssociate at aMoonJeno GyurisPartner at Cure VenturesAsh ZenoozVenture Partner at Aegis VenturesBill Frist, M.D.Co-Founder and Partner at Frist Cressey VenturesPaul VarkiChief Legal Officer at Avalo Therapeutics

+ 1 more

Also attended Princeton University710

Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordKJ SidberryInvestor at GV (Google Ventures)AndrewAdvisor at Clear Ventures

+ 704 more

Also attended Metairie Park Country Day School1

Paul VarkiChief Legal Officer at Avalo Therapeutics

Shared employers

Also worked at Cullinan Therapeutics3

Kristen LaguerreExecutive Partner at MPM BioImpactTony RosenbergManaging Director at MPM BioImpactPaul VarkiChief Legal Officer at Avalo Therapeutics

Also worked at Flexion Therapeutics2

Heath LukatchPartner at Novo HoldingsPaul VarkiChief Legal Officer at Avalo Therapeutics

Also worked at Alexion Pharmaceuticals9

Abbie CelnikerInvestor at Third Rock VenturesSeung Hyun Moon, MD, MPAVenture Partner at Adelphi Ventures Management, LlcRomesh SubramanianVenture Partner at Scion Life SciencesChristina BroomesCommercial Advisor at 2Flo VenturesJohn ReyndersChief Data Scientist & Venture Partner at Iaso VenturesMichihiko WadaChief Regulatory and Development Officer at Newton Biocapital

+ 3 more

Also worked at Centocor8

Deb TraversEntrepreneur-In-Residence at The Innovation SpaceMarian NakadaVice President, Venture Investments at JJDCGregory HarrimanPartner at BioAdvanceMarkwin VeldersAdvisory Committee member at Curie CapitalVenkat KokaInvestment Committee at PS27 VenturesMarian NakadaVice President at Johnson & Johnson Innovation – JJDC

+ 2 more